Baidu
map

BMJ:治疗儿童湿疹 沐浴液添加剂成“鸡肋”?

2018-06-04 徐晓涵 环球医学网

作为一种常见疾病,儿童湿疹可能会给患儿及其家庭带来重大影响。指南建议,完整的润肤疗法是治疗湿疹的主要手段,应定期局部使用糖皮质激素或钙调神经磷酸酶抑制剂。然而,相比于更便宜的肥皂,润肤添加剂真的能获得更好的疗效吗?2018年5月,发表在《BMJ》的一项由英国科学家进行的随机对照试验,考察了润肤浴添加剂治疗儿童湿疹的疗效。

作为一种常见疾病,儿童湿疹可能会给患儿及其家庭带来重大影响。指南建议,完整的润肤疗法是治疗湿疹的主要手段,应定期局部使用糖皮质激素或钙调神经磷酸酶抑制剂。然而,相比于更便宜的肥皂,润肤添加剂真的能获得更好的疗效吗?2018年5月,发表在《BMJ》的一项由英国科学家进行的随机对照试验,考察了润肤浴添加剂治疗儿童湿疹的疗效。

目的:考察在儿童湿疹治疗中添加润肤浴的临床有效性和成本效果。

设计:两个平行组的实用性随机开放式标签的优效性试验。

地点:威尔士和英格兰西部和南部中96家全科医院。

受试者:483名年龄为1至11岁的儿童,符合英国过敏性皮炎的诊断标准。患有轻度湿疹的儿童和每周洗澡次数少于一次的儿童被排除。

结果:干预组受试者由其常规临床小组处方润肤浴添加剂,常规使用12个月。对照组被要求12个月不使用润肤浴添加剂。两组继续接受标准湿疹治疗,包括驻留型润肤剂,监护者被告知如何标准化清洁。

主要结局测试:主要结局是16周后湿疹控制情况(POEM评分,0-7分为轻度;8-16分为中度;17-28分为重度)。次要结局是1年后湿疹严重度(从基线到52周时每月的POEM评分)、湿疹恶化次数、疾病特异性生活质量(皮肤家庭影响)、一般生活质量(儿童健康效用-9D)、医疗资源利用以及局部糖皮质激素或局部钙调神经磷酸酶抑制剂的使用和数量。

结果:483名儿童被随机分配,1名儿童退出,其余482名儿童纳入试验:51%是女孩(244/482),84%是白种人(447/470),平均年龄是5岁。96%(461/482受试者完成至少1次基线后POEM评分,并被纳入分析,77%(370/482)完成主要结局中80%以上时间点的调查问卷(12/16每周调查问卷至16周)。

润肤浴添加剂组的平均基线POEM评分是9.5(标准差[SD]5.7),无润肤浴组是10.1(SD 5.8)。润肤浴添加剂组的16周平均POEM评分是7.5(SD. 6.0),无润肤浴添加剂组是8.4(SD 6.0)。16周后,两组之间每周POEM评分的差异无统计学意义。校正基线严重度和混淆因素(种族,局部糖皮质激素使用,肥皂替代使用)和考虑到中心内受试者的聚类和受试者随时间的反应后,无润肤浴添加剂组的POEM评分比润肤浴添加剂组高0.41分(95%置信区间[CI],-0.27~1.10),低于已发表的POEM最小临床重要差值3分。两组间的次要结局、经济学结局或不良反应无差异。

结论:本试验发现在儿童湿疹标准治疗方案基础上添加润肤浴添加剂无临床益处。未来研究需要考察驻留型润肤剂和肥皂替代品的最佳方案。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2056669, encodeId=1ed7205666928, content=<a href='/topic/show?id=9ed8283397d' target=_blank style='color:#2F92EE;'>#儿童湿疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28339, encryptionId=9ed8283397d, topicName=儿童湿疹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Sat Oct 13 22:21:00 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848531, encodeId=de2b18485311f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Mar 26 06:21:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613780, encodeId=8bc51613e809d, content=<a href='/topic/show?id=b34d662091f' target=_blank style='color:#2F92EE;'>#添加剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66209, encryptionId=b34d662091f, topicName=添加剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9e19427308, createdName=ms6832696159214430, createdTime=Wed Jun 06 08:21:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321456, encodeId=455232145687, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Mon Jun 04 17:29:01 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321455, encodeId=af303214557e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Mon Jun 04 17:25:38 CST 2018, time=2018-06-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2056669, encodeId=1ed7205666928, content=<a href='/topic/show?id=9ed8283397d' target=_blank style='color:#2F92EE;'>#儿童湿疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28339, encryptionId=9ed8283397d, topicName=儿童湿疹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Sat Oct 13 22:21:00 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848531, encodeId=de2b18485311f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Mar 26 06:21:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613780, encodeId=8bc51613e809d, content=<a href='/topic/show?id=b34d662091f' target=_blank style='color:#2F92EE;'>#添加剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66209, encryptionId=b34d662091f, topicName=添加剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9e19427308, createdName=ms6832696159214430, createdTime=Wed Jun 06 08:21:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321456, encodeId=455232145687, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Mon Jun 04 17:29:01 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321455, encodeId=af303214557e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Mon Jun 04 17:25:38 CST 2018, time=2018-06-04, status=1, ipAttribution=)]
    2019-03-26 gaoxiaoe
  3. [GetPortalCommentsPageByObjectIdResponse(id=2056669, encodeId=1ed7205666928, content=<a href='/topic/show?id=9ed8283397d' target=_blank style='color:#2F92EE;'>#儿童湿疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28339, encryptionId=9ed8283397d, topicName=儿童湿疹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Sat Oct 13 22:21:00 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848531, encodeId=de2b18485311f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Mar 26 06:21:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613780, encodeId=8bc51613e809d, content=<a href='/topic/show?id=b34d662091f' target=_blank style='color:#2F92EE;'>#添加剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66209, encryptionId=b34d662091f, topicName=添加剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9e19427308, createdName=ms6832696159214430, createdTime=Wed Jun 06 08:21:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321456, encodeId=455232145687, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Mon Jun 04 17:29:01 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321455, encodeId=af303214557e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Mon Jun 04 17:25:38 CST 2018, time=2018-06-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2056669, encodeId=1ed7205666928, content=<a href='/topic/show?id=9ed8283397d' target=_blank style='color:#2F92EE;'>#儿童湿疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28339, encryptionId=9ed8283397d, topicName=儿童湿疹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Sat Oct 13 22:21:00 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848531, encodeId=de2b18485311f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Mar 26 06:21:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613780, encodeId=8bc51613e809d, content=<a href='/topic/show?id=b34d662091f' target=_blank style='color:#2F92EE;'>#添加剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66209, encryptionId=b34d662091f, topicName=添加剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9e19427308, createdName=ms6832696159214430, createdTime=Wed Jun 06 08:21:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321456, encodeId=455232145687, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Mon Jun 04 17:29:01 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321455, encodeId=af303214557e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Mon Jun 04 17:25:38 CST 2018, time=2018-06-04, status=1, ipAttribution=)]
    2018-06-04 1e145228m78(暂无匿称)

    学习了.谢谢作者分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2056669, encodeId=1ed7205666928, content=<a href='/topic/show?id=9ed8283397d' target=_blank style='color:#2F92EE;'>#儿童湿疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28339, encryptionId=9ed8283397d, topicName=儿童湿疹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Sat Oct 13 22:21:00 CST 2018, time=2018-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848531, encodeId=de2b18485311f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Mar 26 06:21:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613780, encodeId=8bc51613e809d, content=<a href='/topic/show?id=b34d662091f' target=_blank style='color:#2F92EE;'>#添加剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66209, encryptionId=b34d662091f, topicName=添加剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9e19427308, createdName=ms6832696159214430, createdTime=Wed Jun 06 08:21:00 CST 2018, time=2018-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321456, encodeId=455232145687, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Mon Jun 04 17:29:01 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321455, encodeId=af303214557e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba101609906, createdName=happsf, createdTime=Mon Jun 04 17:25:38 CST 2018, time=2018-06-04, status=1, ipAttribution=)]
    2018-06-04 happsf

    学习

    0

相关资讯

抗核治疗后反而病情加重?这个病例太经典了!

老王是温州人,今年64岁了,发病前刚去韩国旅游过,回来后就出现了持续性发热(38℃~38.5℃)伴咳嗽、咳痰、盗汗等症状,同时出现两侧颈部淋巴结肿大伴触痛。2015年11月遂至当地医院就诊,辅助检查结果如下:

Korean J Neurotrauma:创伤性视神经病变的研究进展及治疗

韩国顺天大学富川医院眼科的Jang SY近日在Korean J Neurotrauma发表了一篇综述,系统的讨论了创伤性视神经病变(TON)的研究进展和治疗方案。

罕见病解读系列(2)| 翟振国:面对充满挑战的特发性肺动脉高压:消极迷茫还是积极应对?

近日,国家卫生健康委员会、科技部、工业和信息化部、国家药品监督管理局、国家中医药管理局等五部门联合发布了《第一批罕见病目录》,共收录121种疾病,其中多种为呼吸疾病,为此,我们特约专家对此逐一进行分析解读,敬请关注。

世界遗尿日|儿童尿床可持续到成年,专家呼吁尽早治疗

“曾经有一个20多岁的女孩子因为夜遗尿找我看病,因为我们是儿童医院是不看成人的,她为了挂我们医院的号,还专门把年龄从原来20多岁改成18岁,不然不给她挂号。因为怕被人知道,她不敢出门旅游,不敢交男朋友。”中华医学会儿科分会肾脏学组副组长毛建华教授说,每年儿童夜遗尿是有12-15%的自愈率,但是有很多夜遗尿的患者,他们的症状会持续到成年,甚至有些人终生都会有,“尿床是病,尽早正规治疗对于孩子的

Diabetologia:TRMA综合征中硫胺素治疗的结果

近日,国际杂志 《Diabetologia》上在线发表一项关于糖尿病药物基因组学:TRMA综合征中硫胺素治疗的结果的研究。 糖尿病是硫胺素反应性巨幼细胞性贫血(TRMA)综合征的主要特征之一。目前对这种罕见的单基因型糖尿病亚型的了解有限。研究人员调查了与TRMA相关的糖尿病患者队列中的硫胺素(维生素B 1)的基因型,表型和反应。 研究人员对由Sanger或下一代测序鉴定的32个具有双等

EuroPCR声明:应对当前高血压治疗的挑战!

尽管临床医生为治疗高血压付出很大努力,但其发病率仍在不断增加,目前,已达到全球流行水平,有10亿以上的患者诊断为高血压。虽有很多安全有效的药物,控制率仍很低。因此,本届EuroPCR发表了高血压治疗声明,应进一步开展经导管去肾交感神经术(RDN)治疗高血压的相关研究。

Baidu
map
Baidu
map
Baidu
map